Expand NBSE Menu
NBSE MENU

NBSE Stock Posts


NBSE #NeubaseTherapeutics stock declines -9.2% in after hours trading. See the latest news.

After Hours Decliner

NBSE Neubase Therapeutics6.00+0.18+3.1%

After Hours:5.45-0.55 (-9.2%)

NeuBase Therapeutics Announces Proposed Public Offering of Common Stock

Globe NewswireWed, 21-Apr 4:01 PM
NBSE #NeubaseTherapeutics stock increases 16.0% in premarket,

Premarket Gainer

NBSE Neubase Therapeutics8.05+0.23+2.9%

Premarket:9.34+1.29 (+16.0%)

NeuBase Therapeutics Announces Positive Preclinical In Vivo Data for PATrOL -enabled Anti-gene for the Treatment of Myotonic Dystrophy Type 1

Globe NewswireWed, 16-Dec 6:30 AM
NBSE stock declines -16.8% in premarket,

Premarket Decliner

NBSE Neubase Therapeutics Inc.8.17+0.44+5.7%

Premarket:6.80-1.37 (-16.8%)

NeuBase Therapeutics Announces Proposed Public Offering of Common Stock

Globe NewswireMon, 27-Apr 4:01 PM
NBSE stock declines -15.5% in after hours trading. See the latest news.

After Hours Decliner

NBSE Neubase Therapeutics Inc.8.17+0.44+5.7%

After Hours:6.90-1.27 (-15.5%)

NeuBase Therapeutics Announces Proposed Public Offering of Common Stock

Globe NewswireMon, 27-Apr 4:01 PM
NBSE stock declines -15.1% in after hours trading. See the latest news.

After Hours Decliner

NBSE Neubase Therapeutics Inc.8.17+0.44+5.7%

After Hours:6.94-1.23 (-15.1%)

NeuBase Therapeutics Announces Proposed Public Offering of Common Stock

Globe NewswireMon, 27-Apr 4:01 PM
Load Earlier Posts